News - Patents

Filter

Current filters:

Patents

Popular Filters

201 to 225 of 434 results

Novartis Indian patent hearings close, but no verdict yet

05-12-2012

After more than 12 weeks of hearings in India's Supreme Court, humanitarian aid agency Medecins Sans…

Asia-PacificGlivecLegalNovartisPatentsPharmaceutical

Perrigo in patent settlement with Cadence over Ofirmev

29-11-2012

Cadence Pharmaceuticals (Nasdaq: CADX) has entered into settlement and license agreements with fellow…

Cadence PharmaceuticalsGenericsNeurologicalNorth AmericaOfirmevPatentsPerrigo

EMA workshop on access to clinical-trial data and transparency kicks off process towards proactive publication of data

26-11-2012

"The European Medicines Agency is committed to proactive publication of clinical-trial data, once the…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

European Alzheimer's drug market to grow to $4.78 billion by 2019, says F&S

25-11-2012

The patent expiry of all four existing European Medicines Agency-approved drugs for Alzheimer's disease…

AriceptEbixaEisaiEuropeExelon PatchLundbeckMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalResearch

Generic drugs market will reach $127.8 billion in 2013, Visiongain predicts

20-11-2012

The value of the world prescription generic drug industry stands at $110.8 billion in 2011 and is forecast…

GenericsGlobalMarkets & MarketingPatents

MSF update on Novartis versus India, Supreme Court case

18-11-2012

Humanitarian health organization Medecins Sans Frontieres (MSF) says it continues to follow progress…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

India's Cipla cuts prices of three cancer drugs

12-11-2012

Following what Indian drugmaker Cipla (BSE: 500087) said was an "overwhelming response" on the price…

Asia-PacificcapecitabineCipladocetaxelerlotinibGenericsOncologyPatentsPfizerPharmaceuticalPricingSunitinib MalateSutent

Saudi Arabia aims to improve national health care with patent and drug approval changes

11-11-2012

Saudi Arabia is taking back control of its health care industry, states a new report by the business…

GenericsHealthcareMarkets & MarketingPatentsPharmaceuticalRegulationRest of the World

Canada's Supreme Court paves way for generic Viagra

09-11-2012

There was disappointing news for global pharma behemoth Pfizer (NYSE: PFE) yesterday, when the Canadian…

GenericsLegalMen's HealthNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesViagra

ABPI warns social contract between UK's NHS and Pharma is breaking down

08-11-2012

The UK trade group the Association of the British Pharmaceutical Industry (ABP) has warned that the social…

EuropeHealthcarePatentsPharmaceuticalPoliticsPricing

"New" CDER Exclusivity Board focuses on clarity and consistency of exclusivity decisions

07-11-2012

The US Food and Drug Administration recently announced that the agency has established within the Center…

BiotechnologyLegalNorth AmericaPatentsPharmaceuticalRegulation

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

06-11-2012

US biotech firm Gilead Science's (Nasdaq: GILD) combination drug Stribild (elvitegravir 150mg/cobicistat…

Anti-viralsAtriplaBiotechnologyBristol-Myers SquibbGilead SciencesMarkets & MarketingPatentsReyatazStribildSustiva

FDA approves Teva's Synribo for CML; Novartis plans for Tasigna switch

29-10-2012

The US Food and Drug Administration on Friday approved Israel-headquartered Teva Pharmaceutical Industries'…

GleevecNorth AmericaNovartisOncologyPatentsPharmaceuticalRegulationResearchSynriboTasignaTeva Pharmaceutical Industries

UK govt sets out proposals to cut risks for pharmaceutical research

24-10-2012

A new consultation launched yesterday by the Department for Business, Innovation & Skills (BIS) sets…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

Australian govt details another review on patents

16-10-2012

The Australian government has announced the commission of an expert panel to review the "appropriateness…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

Time to consider longer patent terms, says Medicines Australia

15-10-2012

A new federal government review of Australia's patent system, announced yesterday, should consider the…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

Indonesian government overrides patents on seven HIV and hepatitis drugs

15-10-2012

In a move that was announced in early September but which just came to light last week, the government…

Anti-viralsGenericsPatentsPharmaceuticalPoliticsPricing

EFPIA welcomes Commission policy strategy agenda to strengthen Pharma competitiveness

12-10-2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the European Commission…

BiotechnologyEuropeMarkets & MarketingPatentsPharmaceuticalPoliticsPricing

Overview of Novartis' patent losses from GlobalData

11-10-2012

Swiss drug major Novartis (NOVN: VX) is the latest victim of patent protection loss, note analysts at…

DiovanFemaraFinancialGleevecNovartisPatentsPharmaceuticalReclastZometa

201 to 225 of 434 results

Back to top